CD8A and breast cancer: Alternatively, intratumoral injection of CD25-targeting immunotoxins also potently depletes intratumoral Tregs, leading to CD8+ T cell–mediated tumor regression of inoculated 66c14 breast cancer tumors (Onda et al. 2019).